Core Scientific, Inc./tx (CORZ)

16.51 -6.30% (-1.11)

Over 5Y: +379.9%

2026-08-28
10 20 30
2024 2025 2026

Financials Quarterly

Q3 '25 — Revenue: 81.1M Q3 '25 — Operating Cash Flow: 131.8M Q3 '25 — Free Cash Flow: -112.7M Q3 '25 — Net Income: -144M Q4 '25 — Revenue: 79.8M Q4 '25 — Operating Cash Flow: 157.5M Q4 '25 — Free Cash Flow: -121.7M Q4 '25 — Net Income: 216M Q1 '26 — Revenue: 115.2M Q1 '26 — Operating Cash Flow: 249.9M Q1 '26 — Free Cash Flow: -139.3M Q1 '26 — Net Income: -347.2M Q2 '26 — Revenue: 164.2M Q2 '26 — Operating Cash Flow: -18.9M Q2 '26 — Free Cash Flow: -583.9M Q2 '26 — Net Income: -1.2B -900M -600M -300M 0 300M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 21.3%
OE margin -238.8%
Oper. margin -127.4%
Accruals -37.1%
OCF margin 118.2%
Gross margin 28.3%
Asset turnover 0.084×
Capex / sales 335.7%
EBITDA margin -113.2%
FCF margin -217.5%
Profit margin -324.9%
ROA -27.2%
ROCE -22.3%
OCF / EBIT —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.7
RPO / sales 0.65×
RPO growth -38.7%
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Interest cover -28.5×
Cash / Debt 0.86×
Quick ratio 0.89×
F-score 3.4 pts
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.2
Sales/sh Y/Y +1.6%
Sales CAGR 4Y -12.5%
Sales Q/Q +108.8%
Shares change +24.3%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.